Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

Integer Holdings Corporation (ITGR)

NYSE: ITGR · Electromedical & Electrotherapeutic Apparatus · Plano, TX

Our rating: Neutral

Neutral reaffirmed at $126.59, moderate conviction, October 30, 2026.

Breaks if: The Neutral call turns Positive if two consecutive quarterly filings show revenue growth of 12% or more alongside net margin expanding above 7%. It turns Cautious if revenue growth slips below 5% or net margin compresses below 4% in any two quarterly prints within the next twelve months.

Key figures

Market value$4.3B
Revenue, last 12 months$1.8B
Net income, last 12 months$104M
Free cash flow, last 12 months$82M
Price to earnings41.6×
Free cash flow yield1.9%
Dividend yield0.0%
Operating margin8.2%
Return on equity6.0%
Beta to the S&P 5000.71
Volatility, annualized35.7%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
October 2, 2026$450M−3.9%$0.43$16M
July 3, 2026$464M−2.6%$0.69$37M
April 3, 2026$440M0.5%$0.48$737000.00
December 31, 2025$472M5.0%$1.37$28M
September 26, 2025$468M8.4%$1.11$46M
June 27, 2025$476M11.4%$1.04$25M
March 28, 2025$437M7.3%$-0.66$6M
December 31, 2024$449M11.1%$0.90$44M

Three-model forecasts for the next quarter

Written November 21, 2026, before the report. Each settles from the SEC filing.

11 ledger entries and 76 corporate events on record. Share price as of November 16, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.